Related Experiment Video
Updated: Feb 24, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
Kushal Sejwal1, Mohamed Chami1, Hervé Rémigy2
1Center for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, University of Basel, Basel, 4056, Switzerland.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain protein implicated in the pathogenesis of both familial and sporadic Parkinson's disease (PD), and currently one of the most promising therapeutic targets for drug design in Parkinson's disease. In contrast, LRRK1, the closest homologue to LRRK2, does not play any role in PD. Here, we use cryo-electron microscopy (cryo-EM) and single particle analysis to gain structural insight into the full-length dimeric structures of LRRK2 and LRRK1. Differential scanning fluorimetry-based screening of purification buffers showed that elution of the purified LRRK2 protein in a high pH buffer is beneficial in obtaining high quality cryo-EM images. Next, analysis of the 3D maps generated from the cryo-EM data show 16 and 25 Å resolution structures of full length LRRK2 and LRRK1, respectively, revealing the overall shape of the dimers with two-fold symmetric orientations of the protomers that is closely similar between the two proteins. These results suggest that dimerization mechanisms of both LRRKs are closely related and hence that specificities in functions of each LRRK are likely derived from LRRK2 and LRRK1's other biochemical functions. To our knowledge, this study is the first to provide 3D structural insights in LRRK2 and LRRK1 dimers in parallel.
Insights
Structural insights into Leucine-rich repeat kinase 2 (LRRK2) and LRRK1 dimers were revealed using cryo-electron microscopy. Their similar dimerization mechanisms suggest functional differences arise from other biochemical activities.
Area of Science:
- Structural Biology
- Neuroscience
- Biochemistry
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is a key protein in Parkinson's disease (PD) pathogenesis.
- LRRK2 is a promising therapeutic target for PD drug development.
- LRRK1, LRRK2's homologue, is not associated with PD.
Purpose of the Study:
- To elucidate the structural basis of Leucine-rich repeat kinase 2 (LRRK2) and Leucine-rich repeat kinase 1 (LRRK1) dimerization.
- To compare the full-length dimeric structures of LRRK2 and LRRK1.
Main Methods:
- Cryo-electron microscopy (cryo-EM) and single particle analysis were employed.
- Differential scanning fluorimetry guided purification buffer optimization for LRRK2.
- 3D maps were generated to determine protein structures.
Main Results:
- High-resolution (16 Å for LRRK2, 25 Å for LRRK1) cryo-EM structures of full-length LRRK2 and LRRK1 dimers were obtained.
- Both proteins exhibit similar two-fold symmetric dimer orientations.
- Purification in high pH buffer improved LRRK2 cryo-EM image quality.
Conclusions:
- LRRK2 and LRRK1 share closely related dimerization mechanisms.
- Functional specificities likely stem from other biochemical activities beyond dimerization.
- This study provides the first parallel 3D structural insights into LRRK2 and LRRK1 dimers.

